Cyclin-dependent kinase-1 (Cdk1)/cyclin B1 dictates cell fate after mitotic arrest via phosphoregulation of antiapoptotic Bcl-2 proteins.

作者: Nandini Sakurikar , Joshua M. Eichhorn , Timothy C. Chambers

DOI: 10.1074/JBC.M112.391854

关键词:

摘要: The prevailing model suggests that cell fate after mitotic arrest depends on two independent and competing networks control cyclin B1 degradation the generation of death signals. However, recent evidence for Cdk1/cyclin B1-mediated phosphorylation inactivation antiapoptotic Bcl-2 proteins existence significant cross-talk interdependence between these pathways. Further, nature signals has remained elusive. In this study, we sought to test hypothesis is dictated by robustness signaling identify may represent a signature. We show when treated with Taxol, slippage-resistant HT29 colon carcinoma cells display robust Cdk1 activity extensive Mcl-1/Bcl-xL die in mitosis, whereas slippage-prone DLD-1 weak partial transient subsequent interphase or survive. Furthermore, modulation axis, either inhibition enforcing cells, evokes switch fate, indicating strength key determinant outcome. These findings provide novel insight into pathways regulate death, suggest events be useful as marker define susceptibility antimitotic drugs, encourage revision current describing arrest.

参考文章(26)
D W Shen, C Cardarelli, J Hwang, M Cornwell, N Richert, S Ishii, I Pastan, M M Gottesman, Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. Journal of Biological Chemistry. ,vol. 261, pp. 7762- 7770 ,(1986) , 10.1016/S0021-9258(19)57466-X
David T. Terrano, Meenakshi Upreti, Timothy C. Chambers, Cyclin-Dependent Kinase 1-Mediated Bcl-xL/Bcl-2 Phosphorylation Acts as a Functional Link Coupling Mitotic Arrest and Apoptosis Molecular and Cellular Biology. ,vol. 30, pp. 640- 656 ,(2010) , 10.1128/MCB.00882-09
K. E. Gascoigne, S. S. Taylor, How do anti-mitotic drugs kill cancer cells? Journal of Cell Science. ,vol. 122, pp. 2579- 2585 ,(2009) , 10.1242/JCS.039719
Frank Wolf, Reinhard Sigl, Stephan Geley, '... The end of the beginning': cdk1 thresholds and exit from mitosis. Cell Cycle. ,vol. 6, pp. 1408- 1411 ,(2007) , 10.4161/CC.6.12.4361
Ingrid E. Wertz, Saritha Kusam, Cynthia Lam, Toru Okamoto, Wendy Sandoval, Daniel J. Anderson, Elizabeth Helgason, James A. Ernst, Mike Eby, Jinfeng Liu, Lisa D. Belmont, Joshua S. Kaminker, Karen M. O’Rourke, Kanan Pujara, Pawan Bir Kohli, Adam R. Johnson, Mark L. Chiu, Jennie R. Lill, Peter K. Jackson, Wayne J. Fairbrother, Somasekar Seshagiri, Mary J. C. Ludlam, Kevin G. Leong, Erin C. Dueber, Heather Maecker, David C. S. Huang, Vishva M. Dixit, Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 Nature. ,vol. 471, pp. 110- 114 ,(2011) , 10.1038/NATURE09779
Lindsey A. Allan, Paul R. Clarke, Phosphorylation of Caspase-9 by CDK1/Cyclin B1 Protects Mitotic Cells against Apoptosis Molecular Cell. ,vol. 26, pp. 301- 310 ,(2007) , 10.1016/J.MOLCEL.2007.03.019
Matt Sullivan, David O. Morgan, Finishing mitosis, one step at a time Nature Reviews Molecular Cell Biology. ,vol. 8, pp. 894- 903 ,(2007) , 10.1038/NRM2276
G. R. Rosania, J. Merlie, N. Gray, Y.-T. Chang, P. G. Schultz, R. Heald, A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: Biochemical identification using Xenopus egg extracts Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 4797- 4802 ,(1999) , 10.1073/PNAS.96.9.4797
Margaret E Harley, Lindsey A Allan, Helen S Sanderson, Paul R Clarke, Phosphorylation of Mcl‐1 by CDK1–cyclin B1 initiates its Cdc20‐dependent destruction during mitotic arrest The EMBO Journal. ,vol. 29, pp. 2407- 2420 ,(2010) , 10.1038/EMBOJ.2010.112